Radiographic Surveillance of Patients with Non-BRCA1/2 Pathogenic Variants

被引：0
|
作者：
Laura Hudson
Nicole Gower
Stacy Lenarcic
Sally J. Trufan
Richard L. White
机构：
[1] Levine Cancer Institute,Division of Surgical Oncology, Department of Surgery, Carolinas Medical Center
[2] Levine Cancer Institute,Department of Cancer Biostatistics
[3] Levine Cancer Institute,Department of Genetics
来源：
Annals of Surgical Oncology | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2248 / 2254
页数：6
相关论文
共 50 条
  • [31] PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
    Muranen, Taru
    Morra, Anna
    Khan, Sofia R.
    Barnes, Daniel K.
    Bolla, Manjeet
    Dennis, Joe
    Keeman, Renske
    Leslie, Goska T.
    Parsons, Michael
    Wang, Qin U.
    Ahearn, Thomas
    Aittomaeki, Kristiina L.
    Andrulis, Irene K.
    Arun, Banu
    Behrens, Sabine
    Bialkowska, Katarzyna E.
    Bojesen, Stig J.
    Camp, Nicola
    Chang-Claude, Jenny
    Czene, Kamila
    Devilee, Peter M.
    Domchek, Susan M.
    Dunning, Alison
    Engel, Christoph
    Evans, D. Gareth
    Gago-Dominguez, Manuela
    Garcia-Closas, Montserrat
    Gerdes, Anne-Marie
    Glendon, Gord
    Guenel, Pascal
    Hahnen, Eric
    Hamann, Ute
    Hanson, Helen J.
    Hooning, Maartje
    Hoppe, Reiner
    Izatt, Louise
    Jakubowska, Anna A.
    James, Paul N.
    Kristensen, Vessela
    Lalloo, Fiona J.
    Lindeman, Geoffrey
    Mannermaa, Arto
    Margolin, Sara L.
    Neuhausen, Susan G.
    Newman, William
    Peterlongo, Paolo
    Phillips, Kelly-Anne
    Pujana, Miquel Angel
    Rantala, Johanna
    Ronlund, Karina
    NPJ BREAST CANCER, 2023, 9 (01)
  • [32] High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer
    Kristiansen, M
    Knudsen, GPS
    Maguire, P
    Margolin, S
    Pedersen, J
    Lindblom, A
    Orstavik, KH
    JOURNAL OF MEDICAL GENETICS, 2005, 42 (11) : 877 - 880
  • [33] Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH
    Joosse, Simon A.
    van Beers, Erik H.
    Tielen, Ivon H. G.
    Horlings, Hugo
    Peterse, Johannes L.
    Hoogerbrugge, Nicoline
    Ligtenberg, Marjolijn J.
    Wessels, Lodewyk F. A.
    Axwijk, Priscilla
    Verhoef, Senno
    Hogervorst, Frans B. L.
    Nederlof, Petra M.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (03) : 479 - 489
  • [34] Detection of novel germline mutations for breast cancer in non-BRCA1/2 families
    Aloraifi, F.
    FEBS JOURNAL, 2016, 283 : 5 - 5
  • [35] Detection of novel germline mutations for breast cancer in non-BRCA1/2 families
    Aloraifi, Fatima
    McDevitt, Trudi
    Martiniano, Rui
    McGreevy, Jonah
    McLaughlin, Russell
    Egan, Chris M.
    Cody, Nuala
    Meany, Marie
    Kenny, Elaine
    Green, Andrew J.
    Bradley, Daniel G.
    Geraghty, James G.
    Bracken, Adrian P.
    FEBS JOURNAL, 2015, 282 (17) : 3424 - 3437
  • [36] Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants
    Momozawa, Yukihide
    Sasai, Rumi
    Usui, Yoshiaki
    Shiraishi, Kouya
    Iwasaki, Yusuke
    Taniyama, Yukari
    Parsons, Michael T.
    Mizukami, Keijiro
    Sekine, Yuya
    Hirata, Makoto
    Kamatani, Yoichiro
    Endo, Mikiko
    Inai, Chihiro
    Takata, Sadaaki
    Ito, Hidemi
    Kohno, Takashi
    Matsuda, Koichi
    Nakamura, Seigo
    Sugano, Kokichi
    Yoshida, Teruhiko
    Nakagawa, Hidewaki
    Matsuo, Keitaro
    Murakami, Yoshinori
    Spurdle, Amanda B.
    Kubo, Michiaki
    JAMA ONCOLOGY, 2022, 8 (06) : 871 - 878
  • [37] Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping
    Oldenburg, RA
    Kroeze-Jansema, K
    Meijers-Heijboer, H
    van Asperen, CJ
    Hoogerbrugge, N
    van Leeuwen, I
    Vasen, HFA
    Cleton-Jansen, AM
    Kraan, J
    Houwing-Duistermaat, JJ
    Morreau, H
    Cornelisse, CJ
    Devilee, P
    CLINICAL CANCER RESEARCH, 2006, 12 (06) : 1693 - 1700
  • [38] Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences
    Mary E. Velthuizen
    Rob B. van der Luijt
    Beja J. de Vries
    Marco J. Koudijs
    Eveline M. A. Bleiker
    Margreet G. E. M. Ausems
    Hereditary Cancer in Clinical Practice, 19
  • [39] Breast Cancers with Ocular Metastases are Early Onset, Non-Familial and Non-BRCA1/BRCA2 Tumours
    Katarzyna Królewska
    Anna Jakubowska
    Stanisław Zajączek
    Hereditary Cancer in Clinical Practice, 2 (1)
  • [40] Recontacting non-BRCA1/2 breast cancer patients for germline CHEK2 c.1100del pathogenic variant testing: uptake and patient experiences
    Velthuizen, Mary E.
    van der Luijt, Rob B.
    de Vries, Beja J.
    Koudijs, Marco J.
    Bleiker, Eveline M. A.
    Ausems, Margreet G. E. M.
    HEREDITARY CANCER IN CLINICAL PRACTICE, 2021, 19 (01)
12345